These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Aspects of skeletal muscles in chronic respiratory disease. Man WD Chron Respir Dis; 2016 Aug; 13(3):295-6. PubMed ID: 27488127 [No Abstract] [Full Text] [Related]
26. [The role of altered respiratory mechanics and systemic inflammation in the development of dyspnea in patients with chronic obstructive pulmonary disease]. Belov AA; Lakshina NA Klin Med (Mosk); 2010; 88(1):41-5. PubMed ID: 20369611 [TBL] [Abstract][Full Text] [Related]
27. Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978]. Sin DD; Man SF; Marciniuk DD; Ford G; FitzGerald M; Wong E; York E; Mainra RR; Ramesh W; Melenka LS; Wilde E; Cowie RL; Williams D; Rousseau R; BMC Pulm Med; 2006 Feb; 6():3. PubMed ID: 16460562 [TBL] [Abstract][Full Text] [Related]
28. [Mechanisms of development of osteoporosis in patients with chronic obstructive pulmonary disease]. Klin Med (Mosk); 2011; 89(6):8-12. PubMed ID: 22420187 [TBL] [Abstract][Full Text] [Related]
29. [Management of older adults with COPD]. Hattori K; Kida K Nihon Rinsho; 2016 May; 74(5):858-63. PubMed ID: 27254959 [TBL] [Abstract][Full Text] [Related]
30. The systemic nature of chronic lung disease. Evans RA; Morgan MD Clin Chest Med; 2014 Jun; 35(2):283-93. PubMed ID: 24874124 [TBL] [Abstract][Full Text] [Related]
32. Osteosarcopenia in Patients with Chronic Obstructive Pulmonary Diseases: Which Pathophysiologic Implications for Rehabilitation? Lippi L; Folli A; Curci C; D'Abrosca F; Moalli S; Mezian K; de Sire A; Invernizzi M Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361194 [TBL] [Abstract][Full Text] [Related]
34. Essential amino acids to treat sarcopenia in patients with COPD? Rutten EP; Spruit MA Monaldi Arch Chest Dis; 2010 Mar; 73(1):2-4. PubMed ID: 20499787 [No Abstract] [Full Text] [Related]
35. Implications of the inflammatory response for the identification of biomarkers of chronic obstructive pulmonary disease. Lopez-Campos JL; Calero-Acuña C; Lopez-Ramirez C; Abad-Arranz M; Márquez-Martín E; Ortega-Ruiz F; Arellano E Biomark Med; 2016; 10(2):109-22. PubMed ID: 26808692 [TBL] [Abstract][Full Text] [Related]
36. Anemia is associated with bone mineral density in chronic obstructive pulmonary disease. Rutten EP; Franssen FM; Spruit MA; Wouters EF COPD; 2013 Jun; 10(3):286-92. PubMed ID: 23272661 [TBL] [Abstract][Full Text] [Related]
37. [Bone turnover and bone structure in clinical animal models of COPD.]. Sasaki M; Chubachi S Clin Calcium; 2016; 26(10):1413-1418. PubMed ID: 27666688 [TBL] [Abstract][Full Text] [Related]